Cargando…

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

Background: Cannabidiol (CBD) is a cannabinoid of potential interest for the treatment of substance use disorders. Our aim was to review the outcome measures, surrogate endpoints, and biomarkers in published and ongoing randomized clinical trials. Methods: We conducted a search in PubMed, Web of Sci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morel, Alix, Lebard, Pierre, Dereux, Alexandra, Azuar, Julien, Questel, Frank, Bellivier, Frank, Marie-Claire, Cynthia, Fatséas, Mélina, Vorspan, Florence, Bloch, Vanessa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937926/ https://www.ncbi.nlm.nih.gov/pubmed/33692705 http://dx.doi.org/10.3389/fpsyt.2021.565617

Ejemplares similares

Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders
por: Therribout, Norman, et al.
Publicado: (2022)

Ascorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study
por: Clergue-Duval, Virgile, et al.
Publicado: (2021)

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review
por: Poireau, Margaux, et al.
Publicado: (2022)

The Impact of Co-occurring Post-traumatic Stress Disorder and Substance Use Disorders on Craving: A Systematic Review of the Literature
por: Renaud, Fabien, et al.
Publicado: (2021)

Risk and Protective Factors of Lifetime Cocaine-Associated Chest Pain
por: Clergue-Duval, Virgile, et al.
Publicado: (2021)

Patients With Severe Alcohol-Related Cognitive Impairment Improve in Flexibility When Abstinence Is Maintained: A Comparative Study With Alzheimer’s Disease
por: Clergue-Duval, Virgile, et al.
Publicado: (2022)

Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders
por: Icick, Romain, et al.
Publicado: (2021)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019)

A single case report of STN-DBS for severe crack-cocaine dependence: double-blind ON vs. SHAM randomized controlled assessment
por: Vorspan, Florence, et al.
Publicado: (2023)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

A specific cognitive behavioral group therapy program for stimulant use disorder
por: Karsinti, Emily, et al.
Publicado: (2022)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users
por: Cabé, Julien, et al.
Publicado: (2021)

Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study
por: Cleirec, Grégoire, et al.
Publicado: (2018)

Using density of antecedent events and trajectory path analysis to investigate family-correlated patterns of onset of bipolar I disorder: a comparison of cohorts from Europe and USA
por: Scott, Jan, et al.
Publicado: (2021)

Correction to: Using density of antecedent events and trajectory path analysis to investigate family-correlated patterns of onset of bipolar I disorder: a comparison of cohorts from Europe and USA
por: Scott, Jan, et al.
Publicado: (2021)

Editorial: Dual disorders (addictive and concomitant psychiatric disorders): Mechanisms and treatment
por: Vorspan, Florence, et al.
Publicado: (2022)

Lockdown Impact on Stress, Coping Strategies, and Substance Use in Teenagers
por: Bourduge, Cédrine, et al.
Publicado: (2022)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
por: Scott, Jan, et al.
Publicado: (2018)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Are empty methadone bottles empty? An analytic study
por: Dupuy, Gaël, et al.
Publicado: (2014)

Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study
por: Icick, Romain, et al.
Publicado: (2022)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Surrogate endpoints in early prostate cancer research
por: Williams, Scott
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Alcohol Withdrawal Is an Oxidative Stress Challenge for the Brain: Does It Pave the Way toward Severe Alcohol-Related Cognitive Impairment?
por: Clergue-Duval, Virgile, et al.
Publicado: (2022)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
por: Niesink, Raymond J. M., et al.
Publicado: (2013)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap
por: Cleirec, Grégoire, et al.
Publicado: (2022)

Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances
por: Vorspan, Florence, et al.
Publicado: (2020)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ckbtafbmmdv7rjhous5s6lnp6d